Status:

COMPLETED

Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH

Lead Sponsor:

Stanford University

Collaborating Sponsors:

Mallinckrodt

Conditions:

Kidney Diseases

Eligibility:

All Genders

16-65 years

Phase:

PHASE4

Brief Summary

FSGS is an immunologic disorder wherein circulating immune proteins cause damage to the kidneys and progressive injury and scarring. Corticosteroid therapy is occasionally, but not nearly universally,...

Detailed Description

EXPERIMENTAL TREATMENT: Patients with biopsy proven FSGS will be treated with ACTH in an open-label pilot study of tolerability and efficacy. The investigators will recruit 18-20 patients to complete ...

Eligibility Criteria

Inclusion

  • 1\. Biopsy proven FSGS
  • 2\. Ability to consent and complete study evaluations
  • 3\. Greater than 2g/day of proteinuria
  • 4\. No contraindications to treatment with corticosteroids or ACTH
  • 5\. Women of childbearing potential will agree to use effective forms of birth control throughout this study

Exclusion

  • 1\. Known secondary cause of FSGS
  • 2\. Receiving active immune therapy (within 90 days)
  • 3\. Pregnancy
  • 4\. Creatinine \>2.5 mg/dl
  • 5\. Uncontrolled HTN (\>180/100mm Hg)
  • 6\. Diabetes
  • 7\. Acute or chronic infection
  • 8\. Severe comorbidity (active coronary, cerebrovascular disease, cancer, psychiatric disease)
  • 9\. Age \< 16, \>65 years
  • 10\. Evidence of untreated tuberculosis (+PPD or Ellispot Gold testing)
  • 11\. A known contraindication to ACTH. Corticotropin is considered contraindicated in patients with scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex, recent surgery, history of or the presence of a peptic ulcer, congestive heart failure, uncontrolled hypertension, or sensitivity to proteins of porcine origin.

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01155141

Start Date

September 1 2009

End Date

January 1 2014

Last Update

September 1 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University School of Medicine

Stanford, California, United States, 94305